Patheon
Thermo Fisher buying Patheon for $5.2 billion
Deal expected to close by the end of the year.
Royal DSM to buy Canadian drugmaker Patheon for $195M
Deal combines chemical company to create larger independent drug manufacturer.
Deal expected to close by the end of the year.
Deal combines chemical company to create larger independent drug manufacturer.